Orthovita to submit Orthocomp bone cement 510(k) in second quarter.
This article was originally published in The Gray Sheet
Executive Summary
ORTHOVITA's ORTHOCOMP BONE CEMENT 510(K) SUBMISSION for use in non-load bearing applications is scheduled for the second quarter, according to the firm. Speaking at a Jan. 27 session of the Rodman and Renshaw musculoskeletal devices conference in Boston, Senior VP Samuel Nalbone said the firm hopes the bioactive, self-setting bone bonding composite will "replace" polymethylmethacrylate (PMMA) cement due to its superior mechanical properties, biological bone-bonding interface and simple delivery and mixing system.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.